Cancer pain
Conditions
Interventions
Trial group:Pharmaceutical Care Electronic Management System
Sponsors
Fujian Medical University Union Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: (1) patient be able to read Chinese and use a mobile phone; (2) patient aged between 18 and 70 years; (3) patient be diagnosed with cancer and had self-reported cancer pain within a month prior to the study; (4) patient is under standard analgesia treatments; (5) the patient was estimated to have over 2 months survival time; (6) The patients must understand the study process and evaluation, agree to participate in this trial, and sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Patients who self-reported to have severe cognitive impairments; 2. hepatic insufficiency (ALT=2.5×ULNAST=2.5×ULNTBIL=1.5×ULN), renal insufficiency (Cr=2.5×ULN); 3. Patients who unable to complete pain assessment; 4. participating in any other investigational therapies or other study protocols that may have an impact on pain intensity which are the main outcomes of this study; 5. history of drug abuse, history of drug addiction or severe alcoholism; 6. Opioid allergy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of life;Compliance; | — |
Countries
China
Contacts
Public ContactLiu Maobai
Fujian Medical University Union Hospital
Outcome results
None listed